Attachment of hepatitis C virus to cultured cells: A novel predictive factor for successful interferon therapy

Journal of Medical Virology

Volumn 56, Issue 1, 1998, Pages 25-32

  Kimura, Yoichi ^a   Hayashida, Kazuhiro ^a   Ishibashi, Hiromi ^a   Niho, Yoshiyuki ^a   Akazawa, Kouhei ^b   Yanagi, Yusuke ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Immune complex; Immunoprecipitation; PCR

Indexed keywords

ALANINE AMINOTRANSFERASE; INTERFERON; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ADULT; AGED; ARTICLE; CELL ADHESION; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; IMMUNOPRECIPITATION; INTRAMUSCULAR DRUG ADMINISTRATION; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; REGRESSION ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRION;

ADULT; CELLS, CULTURED; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERONS; MALE; MIDDLE AGED; PRECIPITIN TESTS; PREDICTIVE VALUE OF TESTS; RNA, VIRAL;

HEPATITIS C VIRUS;

EID: 0031872262     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199809)56:1<25::AID-JMV5>3.0.CO;2-P     Document Type: Article

References (27)

1. Bryson MC, Johnson ME (1981): The incidence of monotone likelihood in the Cox model. Technometrics 23:381-383.
2. Chemello L, Bonetti P, Cavalletto L, Talato F, Donadon V, Casarin P, Belussi F, Frezza M, Noventa F, Pontisso P, Benvegnu L, Casarin C, Alberti A, the TriVeneeto Viral Hepatitis Group (1995): Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. Hepatology 22:700-706.
3. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989): Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
4. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Jr., Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, Vanthiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A, the Hepatitis Interventional Therapy Group (1989): Treatment of chronic hepatitis C with recombinant interferon-alpha: A multicenter randomized, controlled trial. New England Journal of Medicine 321:1501-1506.
5. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, Banks SM, Hoofnagle JH (1989): Recombinant interferon-alpha therapy for chronic hepatitis C: A randomized, double-blind, placebo-controlled trial. New England Journal of Medicine 321:1506-1510.
6. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C (1996): Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. New England Journal of Medicine 334:77-81.
7. Farci P, Alter HJ, Wong DC, Miller RH, Govindarajan S, Engle R, Shapiro M, Purcell RH (1994): Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proceedings of the National Academy of Sciences U.S.A. 91:7792-7796.
8. Garson JA, Brillanti S, Whitby K, Foli M, Deaville R, Masci C, Miglioli M, Barbara L (1995): Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C. Journal of Medical Virology 45:348-353.
9. Hijikata M, Shimizu YK, Kato H, Iwamoto A, Shih JW, Alter HJ, Purcell RH, Yoshikura H (1993): Equilibrium centrifugation studies of hepatitis C virus: Evidence for circulating immune complexes. Journal of Virology 67:1953-1958.
10. Hino K, Sainokami S, Shimoda K, Iino S, Wang Y, Okamoto H, Miyakawa Y, Mayumi M (1994): Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. Journal of Medical Virology 42:299-305.
11. Ito T, Mukaigawa J, Zuo J, Hirabayashi Y, Mitamura K, Yasui K (1996): Cultivation of hepatitis C virus in primary hepatocyte culture from patients with chronic hepatitis C results in release of high-titer infectious virus. Journal of General Virology 77:1043-1054.
12. Kato N, Yokosuka O, Hosoda K, Ito Y, Ohto M, Omata M (1993): Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: Increase of the virus in advanced liver disease. Hepatology 18:16-20.
13. Kato N, Nakazawa T, Mizutani T, Shimotohno K (1995): Susceptibility of human T-lymphotropic virus type I-infected cell line MT-2 to hepatitis C virus infection. Biochemical & Biophysical Research Communications 206:863-869.
14. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH, Alter HJ (1990): Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 12:671-675.
15. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee WS, Kuo C, Berger K, Shuster JR, Overby LR, Bradley DW, Houghton M (1989): An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362-364.
16. Mahaney K, Tedeschi V, Maertens G, Di Bisceglie AM, Vergalla J, Hoofnagle JH, Sallie R (1994): Genotypic analysis of hepatitis C virus in American patients. Hepatology 20:1405-1411.
17. Mita E, Hayashi N, Hagiwara H, Ueda K, Kanazawa Y, Kashara A, Fusamoto H, Kamada T (1994): Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer. Digestive Diseases & Sciences 39:977-982.
18. Nakatsuji Y, Matsumoto A, Tanaka E, Ogata H, Kioysawa K (1992): Detection of chronic hepatitis C virus infection by four diagnostic systems: First-generation and second-generation enzyme-linked immunosorbent assay, second-generation recombinant immunoblot assay and nested polymerase chain reaction analysis. Hepatology 16:300-305.
19. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M (1992): Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. Journal of General Virology 73:673-679.
20. Shimizu YK, Purcell RH, Yoshikura H (1993): Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro. Proceedings of the National Academy of Sciences U.S.A. 90: 6037-6041.
21. Shimizu YK, Yoshikura H (1994): Multicycle infection of hepatitis C virus in cell culture and inhibition by alpha and beta interferons. Journal of Virology 68:8406-8408.
22. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H (1994): Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. Journal of Virology 68:1494-1500.
23. Thomssen R, Bonk S, Thiele A (1993): Density heterogeneities of hepatitis C virus in human sera due to the binding of b-lipoproteins and immunoglobulins. Medical Microbiology and Immunology 182:329-334.
24. Weiner AJ, Brauer MJ, Kosenblatt J, Richman KH, Tung J, Crawford K, Bonino F, Saracco G, Choo QL, Houghton M, Han JH (1991): Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 180:842-848.
25. Yoshioka K, Aiyama T, Okumura A, Takayanagi M, Iwata K, Ishikawa T, Nagai Y, Kakumu S (1997): Humoral immune response to the hypervariable region of hepatitis C virus differs between genotypes 1b and 2a. Journal of Infectious Diseases 175:505-510.
26. Yuki N, Hayashi N, Mita E, Hagiwara H, Oshita M, Ohkawa K, Katayama K, Kasahara A, Fusamoto H, Kamada T (1995): Clinical characteristics and antibody profiles of chronic hepatitis C patients: Relation to hepatitis C virus genotypes. Journal of Medical Virology 45:162-167.
27. Zibert A, Schreier E, Roggendorf M (1995): Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 208:653-661.